IRF-3 has been previously shown to contribute to an antiviral state by activating ISGs, including ISG54 and ISG56, in an IFN-dependent and -independent manner in fibroblasts and epithelial cells infected with HSV, VSV, Newcastle disease, vaccinia, and Sendai viruses [31]. This evidence concerns the gene IRF3 and Newcastle disease.